Showing 2 of 2 recruiting trials for “Malignant melanoma of the mucosa”
A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy
Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →